amphetamine has been researched along with Daytime Sleepiness in 7 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Modafinil is a newly discovered waking substance now being used in the treatment of hypersomnia and narcolepsy." | 1.31 | Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat. ( Frydman, A; Gervasoni, D; Hou, Y; Jouvet, M; Lin, JS; Rambert, F; Vanni-Mercier, G, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Krief, S | 1 |
| Berrebi-Bertrand, I | 1 |
| Nagmar, I | 1 |
| Giret, M | 1 |
| Belliard, S | 1 |
| Perrin, D | 1 |
| Uguen, M | 1 |
| Robert, P | 1 |
| Lecomte, JM | 1 |
| Schwartz, JC | 1 |
| Finance, O | 1 |
| Ligneau, X | 1 |
| Nishino, S | 2 |
| Elkay, M | 1 |
| Bergin, AM | 1 |
| Kothare, SV | 1 |
| GALLINEK, A | 1 |
| Soya, A | 1 |
| Song, YH | 1 |
| Kodama, T | 1 |
| Honda, Y | 1 |
| Fujiki, N | 1 |
| Lin, JS | 1 |
| Gervasoni, D | 1 |
| Hou, Y | 1 |
| Vanni-Mercier, G | 1 |
| Rambert, F | 1 |
| Frydman, A | 1 |
| Jouvet, M | 1 |
| Ugoljew, A | 1 |
| Kurella, B | 1 |
| Nickel, B | 1 |
7 other studies available for amphetamine and Daytime Sleepiness
| Article | Year |
|---|---|
Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Carbamates; Corp | 2021 |
Rebound hypersomnolence, stimulant abuse, and DAT-mediated dopamine release.
Topics: Amphetamine; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Dopamine Agents; | 2009 |
Clinical reasoning: a teenage girl with excessive daytime sleepiness, "fainting spells," and dream mentations.
Topics: Adolescent; Amphetamine; Central Nervous System Stimulants; Dextroamphetamine; Disorders of Excessiv | 2010 |
Syndrome of episodes of hypersomnia, bulimia, and abnormal mental states.
Topics: Amphetamine; Amphetamines; Bulimia; Depression; Disorders of Excessive Somnolence; Humans; Hunger; M | 1954 |
CSF histamine levels in rats reflect the central histamine neurotransmission.
Topics: Amphetamine; Animals; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Circadian Rhyt | 2008 |
Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat.
Topics: Amphetamine; Animals; Benzhydryl Compounds; Cats; Central Nervous System Stimulants; Disorders of Ex | 2000 |
[Sleep polygraphic studies as an objective method for assessing the therapeutic result in a case of periodic hypersomnia (Kleine-Levin syndrome)].
Topics: Adult; Amphetamine; Cerebral Cortex; Disorders of Excessive Somnolence; Drug Therapy, Combination; E | 1991 |